NCT06666582Completed
Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer
Real-world Efficacy and Toxicity Data of the Combination of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Patients With Advanced Gastric Cancer
Source: ClinicalTrials.gov · Last updated 30 Oct 2024
Brief summary (registry, in English)
Our aim was to evaluate whether second-line treatment with paclitaxel and ramucirumab was associated with improved clinical outcomes compared to other available therapies. This study involved real-world data collection, focusing on the safety and efficacy of therapeutic combinations, administered to patients with pretreated advanced gastric cancer in the Oncology Departments affiliated with the Hellenic Cooperative Oncology Group (HeCOG).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 185 (actual)
- First submitted
- 9 Apr 2024
- Start date
- 1 Mar 2015
- Primary completion date
- 30 Mar 2023
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06666582
What you commit to
- Study type: Observational
- Participants enrolled: 185
- From 1 Mar 2015 to the primary completion date, 30 Mar 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Lack of informed consent in case the patient was alive
Who the study is looking for
- Patients with unresectable or metastatic, locally advanced adenocarcinoma of the stomach, gastroesophageal junction, or distal esophagus
- Treated at Departments of Medical Oncology affiliated with the Hellenic Cooperative Oncology Group (HeCOG)
- Second-line treatment for advanced disease
- Treatment for at least two months of second-line treatment.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hellenic Oncology Cooperative Group Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.